Looking for exceptional Pharmacokinetic, Bioequivalent, Toxicokinetic or Residual studies?

Thanks to our advanced technology, techniques, and highly sensitive ICP/MS tech, QUINTA-ANALYTICA’s bioanalytical department is capable of conducting elemental analyses of extremely minute trace elements in biological matrices such as urine, plasma, blood serum & tissues.

With very low detection limits in the order of parts per billion, we can determine the given element not only in terms of total concentration, but also the form in which the monitored element is contained in the given matrix (using speciation analysis). This is essential for assessing the efficacy of drugs or dietary supplements containing trace elements.

A perfect example: a methodology we’re currently establishing to determine serum iron after administration of a colloidal form of iron (i.e. Ferric carboxymaltose) used in the treatment of anaemia. Our analyses can be used to determine both total iron in the blood serum plus its individual forms (labile iron, iron bound to transferrin, colloidal iron).

We think that’s pretty cool!

Curious to know how we do it, or more about our services? Get in touch.

Additional News

  • 17 December 2025

    PF 2026: Thank You from Quinta-Analytica

    In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.

  • 15 December 2025

    IVBE for locally acting drugs: insights from Conscio Science Day in Munich

    Can bioequivalence for locally acting drugs be demonstrated without a single subject in a clinical trial? Yes, if your in vitro bioequivalence (IVBE) toolkit is set up in the right way.

  • 20 November 2025

    Webinar: Streamlined Evidence Strategies for Biosimilars: Analytics, PK and Immunogenicity in focus

    On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar from biosimilar series.